SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Oppenheimer Maintains Outperform on Medtronic, Lowers Price Target to $112

Oppenheimer maintains Medtronic (NYSE:MDT) with a Outperform and lowers the price target from $131 to $112.

Benzinga · 05/22/2020 13:41

Oppenheimer maintains Medtronic (NYSE:MDT) with a Outperform and lowers the price target from $131 to $112.